Kimera is a biotechnology company that develops perinatal exosome products for the treatment of burns, orthopedics, COPD and inflammatory diseases... Read more
Kimera is a biotechnology company that develops perinatal exosome products for the treatment of burns, orthopedics, COPD and inflammatory diseases... Read more
News
Jun 01, 2026
StreetInsider
Press Release: Kimera Labs : Kimera Labs Implements ISO 9001:2015, ISO 13485:2016, and ISO 22716:2007 Across Its Miramar Manufacturing Facility
May 12, 2025
FinanzNachrichten
Kimera Labs: Kimera Labs Inc: Kimera Labs Named Semifinalist in $101 Million XPRIZE Healthspan Competition for Pioneering Innovations in Healthy Aging
Feb 20, 2024
FinanzNachrichten
Kimera Labs: Kimera Labs Inc: Kimera Labs Inc publishes novel brain targeting of exosomes in Nature Scientific Reports
Jan 23, 2024
StreetInsider
Press Release: Kimera Labs : Kimera Labs Responds to FDA Warning Letter
May 16, 2023
FinanzNachrichten
Kimera Labs: Kimera Labs Inc: Kimera Labs Receives FDA Phase I/IIa IND Approval For Its MSC Exosomes Human Study
May 16, 2023
MediaBrief
Kimera Labs: Coriander Kitchen at Conrad Pune invites guets for a Coast-to-Coast Menu
Mar 09, 2023
EIN Presswire
Press Release: Kimera Labs : Kimera Launches Luxir , the Next-Generation MSC Exosome Product
Apr 22, 2022
Markets Insider
Kimera Labs: Kimera Labs Files Lawsuit against Exocel Bio Inc, CEO for Alleged Theft of Trade Secrets
Mar 11, 2021
Markets Insider
Kimera Labs: Kimera Labs Announces New Standard Measurement For Exosome Potency, Characterization
Aug 18, 2020
PR Newswire
Press Release: Kimera Labs : Kimera Labs Files First FDA Investigational New Drug (IND) Application Using XoGlo for Treatment of ARDS Secondary to COVID-19
Kimera Labs Competitors
1
2
3
4
5
6
7
8
9
10